|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 37/02 | |
| C07K 16/00 | |||
| A01K 67/027 | |||
| C07K 16/46 | |||
| C12N 15/85 |
| (11) | Patento numeris | 3028564 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16151214.0 |
| Europos patento paraiškos padavimo data | 2010-07-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0911846 | 2009-07-08 | GB | |
| 223960 P | 2009-07-08 | US | |
| 0913102 | 2009-07-28 | GB | |
| 355666 P | 2010-06-17 | US |
| (72) |
BRADLEY, Allan, GB
LEE, E-Chiang, GB
LIANG, Qi, GB
WANG, Wei, GB
|
| (73) |
Kymab Limited,
The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT,
GB
|
| (54) | ANIMAL MODELS AND THERAPEUTIC MOLECULES |
| ANIMAL MODELS AND THERAPEUTIC MOLECULES |